Cardiac Resynchronization Therapy in Women

Area of Science:

• Cardiology
• Medical Devices

Background:

• Cardiac resynchronization therapy (CRT) improves heart failure outcomes.
• Women are underrepresented in clinical trials for CRT.
• Existing data suggest women experience greater clinical benefits from CRT than men.

Purpose of the Study:

• To evaluate the efficacy of CRT in women with heart failure.
• To investigate the impact of QRS duration thresholds on CRT eligibility in women.

Main Methods:

• Review of existing clinical studies on CRT in heart failure patients.
• Analysis of CRT response rates across different demographic groups, focusing on sex differences.
• Examination of QRS duration criteria in relation to CRT benefits in female populations.

Main Results:

• Women exhibit a high CRT response rate (90%) across a broad QRS duration range (130-175 ms).
• Women are more frequently diagnosed with left bundle branch block, a common indication for CRT.
• A QRS duration threshold of 150 ms may disqualify many women who would benefit from CRT.

Conclusions:

• Current CRT prescription guidelines based on QRS duration may be suboptimal for women.
• Revising CRT eligibility criteria could improve access to this therapy for female heart failure patients.
• Further research is warranted to optimize CRT use in women.